Integra F (US Pharmaceutical Corporation)


Welcome to the PulseAid listing for the Integra F drug offered from US Pharmaceutical Corporation. This Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: US Pharmaceutical Corporation
NON-PROPRIETARY NAME: Ferrous Fumarate and Polysacchride Iron Complex and Folic Acid
SUBSTANCE NAME: FERROUS FUMARATE; FERROUS ASPARTO GLYCINATE; FOLIC ACID; ASCORBIC ACID; NIACIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2009-04-27
END MARKETING DATE: 0000-00-00


Integra F HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIntegra F from US Pharmaceutical Corporation
LABELER NAME: US Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 191.2; 135.9; 1; 40; 3(mg/1; mg/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 2009-04-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52747-711_61d8deac-80ef-45b0-b812-6c824bd1a869
PRODUCT NDC: 52747-711
APPLICATION NUMBER:

Other FERROUS FUMARATE; FERROUS ASPARTO GLYCINATE; FOLIC ACID; ASCORBIC ACID; NIACIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
US Pharmaceutical CorporationIntegra F